Salvage therapy and formulation of highly active antiretroviral therapy

被引：0
|
作者：
Fessel, WJ [1 ]
Follansbee, SE [1 ]
Young, TP [1 ]
机构：
[1] Permanente Med Grp Inc, San Francisco, CA USA
来源：
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2000年 / 24卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：194 / 195
页数：2
相关论文
共 50 条
  • [21] Cervical neoplasia and highly active antiretroviral therapy
    Xi, LF
    Kiviat, NB
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (14): : 1051 - 1053
  • [22] Gynecomastia associated with highly active antiretroviral therapy
    Manfredi, R
    Calza, L
    Chiodo, F
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (04) : 438 - 439
  • [23] Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy
    Sabin, CA
    Smith, CJ
    Gumley, H
    Murphy, G
    Lampe, FC
    Phillips, AN
    Prinz, B
    Youle, M
    Johnson, MA
    AIDS, 2004, 18 (16) : 2145 - 2151
  • [24] Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy
    Barrón, Y
    Cole, SR
    Greenblatt, RM
    Cohen, MH
    Anastos, K
    DeHovitz, JA
    Delapenha, R
    Gange, SJ
    AIDS, 2004, 18 (11) : 1579 - 1584
  • [25] Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy
    Breen, RAM
    Miller, RF
    Gorsuch, T
    Smith, CJ
    Ainsworth, J
    Ballinger, J
    Swaden, L
    Cropley, I
    Johnson, MA
    Lipman, MCI
    JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (10): : 1437 - 1440
  • [26] Highly active antiretroviral therapy and the kidney: An update on antiretroviral medications for nephrologists
    Berns, Jeffrey S.
    Kasbekar, Nishaminy
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (01): : 117 - 129
  • [27] Dealing with the obstacles in adhering to highly active antiretroviral therapy
    Hubbard, M
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2006, 17 (01): : 18 - 25
  • [28] Cytomegalovirus retinitis in the era of highly active antiretroviral therapy
    Zegans, M
    Marsh, B
    Walton, RC
    INTERNATIONAL OPHTHALMOLOGY CLINICS, 2000, 40 (02) : 127 - 135
  • [29] HIV transmission under highly active antiretroviral therapy
    Vernazza, Pietro
    Hirschel, Bernard
    Bernasconi, Enos
    Flepp, Markus
    LANCET, 2008, 372 (9652): : 1806 - 1807
  • [30] Neurocognitive dysfunction in the highly active antiretroviral therapy era
    Mothobi, Nomvuyo Z.
    Brew, Bruce J.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (01) : 4 - 9
12345